Reuters logo
BRIEF-Stellar Biotechnologies, Matrivax sign agreement to transfer vaccine technology
2017年3月13日 / 晚上9点16分 / 7 个月前

BRIEF-Stellar Biotechnologies, Matrivax sign agreement to transfer vaccine technology

March 13 (Reuters) - Stellar Biotechnologies Inc

* Stellar Biotechnologies and Matrivax sign agreement to transfer vaccine technology

* Stellar Biotechnologies says Stellar will transfer its proprietary rights and know-how of immunogens and vaccine technology for clostridium difficile Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below